Pseudohypoparathyroidism (PHP) is a heterogeneous orphan disease characterized by multihormonal resistance and several phenotypic features. In some cases, PHP is caused by a mutation in the GNAS that encodes the alpha subunit of the G protein, one of the key transmitters of intracellular signals. A correlation between the genotype and phenotype of patients with GNAS mutations has not yet been described. This often makes diagnosis, drug prescription, and timely diagnosis difficult. Information about GNAS functioning and the impact of specific mutations on the clinical course of the disease is limited. Establishing of the pathogenicity by newly identified GNAS mutations will expand the understanding of this gene functioning in the cAMP signal...
Pseudohypoparathyroidism-Ia and -Ib (PHP-Ia and -Ib) are caused by mutations in GNAS exons 1-13 and ...
Purpose: Pseudohypoparathyroidism (PHP), characterized by multihormone resistance and Albright’s her...
International audienceABSTRACT Pseudohypoparathyroidism type 1A (PHP1A) and pseudopseudohypoparathyr...
Pseudohypoparathyroidism (PHP) is a rare heterogeneous genetic disorder characterized by end-organ r...
Pseudohypoparathyroidism type Ia (PHP Ia) is defined as a series of disorders characterized by multi...
OBJECTIVE: Mutations of the GNAS1 gene, which is located on chromosome 20q13.11 and encodes the alph...
Pseudohypoparathyroidism (PHP) refers to two major variants that generally coexist in the same famil...
Pseudohypoparathyroidism type Ia (PHP Ia) is a rare disease characterized by an elevated parathyroid...
International audiencePseudohypoparathyroidism type 1A (PHP1A) and pseudopseudohypoparathyroidism (P...
<b>OBJECTIVE:</b> Mutations of the GNAS1 gene, which is located on chromosome 20q13.11 a...
Pseudohypoparathyroidism (PHP) is a heterogeneous disease characterized by PTH resistance and classi...
Pseudohypoparathyroidism (PHP) is a heterogeneous disease characterized by PTH resistance and classi...
Context: Pseudohypoparathyroidism type Ia (PHP1A) is a rare endocrine disorder characterized by hypo...
Pseudohypoparathyroidism type Ia (PHP-Ia) is characterized by multihormone resistance and an Albrigh...
Pseudohypoparathyroidism (PHP) is a disorder characterized by hypocalcemia and hyperphosphatemia due...
Pseudohypoparathyroidism-Ia and -Ib (PHP-Ia and -Ib) are caused by mutations in GNAS exons 1-13 and ...
Purpose: Pseudohypoparathyroidism (PHP), characterized by multihormone resistance and Albright’s her...
International audienceABSTRACT Pseudohypoparathyroidism type 1A (PHP1A) and pseudopseudohypoparathyr...
Pseudohypoparathyroidism (PHP) is a rare heterogeneous genetic disorder characterized by end-organ r...
Pseudohypoparathyroidism type Ia (PHP Ia) is defined as a series of disorders characterized by multi...
OBJECTIVE: Mutations of the GNAS1 gene, which is located on chromosome 20q13.11 and encodes the alph...
Pseudohypoparathyroidism (PHP) refers to two major variants that generally coexist in the same famil...
Pseudohypoparathyroidism type Ia (PHP Ia) is a rare disease characterized by an elevated parathyroid...
International audiencePseudohypoparathyroidism type 1A (PHP1A) and pseudopseudohypoparathyroidism (P...
<b>OBJECTIVE:</b> Mutations of the GNAS1 gene, which is located on chromosome 20q13.11 a...
Pseudohypoparathyroidism (PHP) is a heterogeneous disease characterized by PTH resistance and classi...
Pseudohypoparathyroidism (PHP) is a heterogeneous disease characterized by PTH resistance and classi...
Context: Pseudohypoparathyroidism type Ia (PHP1A) is a rare endocrine disorder characterized by hypo...
Pseudohypoparathyroidism type Ia (PHP-Ia) is characterized by multihormone resistance and an Albrigh...
Pseudohypoparathyroidism (PHP) is a disorder characterized by hypocalcemia and hyperphosphatemia due...
Pseudohypoparathyroidism-Ia and -Ib (PHP-Ia and -Ib) are caused by mutations in GNAS exons 1-13 and ...
Purpose: Pseudohypoparathyroidism (PHP), characterized by multihormone resistance and Albright’s her...
International audienceABSTRACT Pseudohypoparathyroidism type 1A (PHP1A) and pseudopseudohypoparathyr...